Publication | Open Access
A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission
57
Citations
21
References
2016
Year
NCT00808509.
| Year | Citations | |
|---|---|---|
Page 1
Page 1